Skip to main content Accessibility help
×
Hostname: page-component-54dcc4c588-wlffp Total loading time: 0 Render date: 2025-09-30T07:16:31.866Z Has data issue: false hasContentIssue false
Coming soon

Innovation versus Financialization in the US Pharmaceutical Industry

Expected online publication date:  03 November 2025

Öner Tulum
Affiliation:
The Academic-Industry Research Network
William Lazonick
Affiliation:
The Academic-Industry Research Network

Summary

Mandated by the Inflation Reduction Act of 2022, the US government is negotiating with pharmaceutical companies over the 'maximum fair price' of ten drugs widely used by Medicare patients. The pharmaceutical companies contend that a 'fair' price is a 'value-based price' that enables their shareholders to capture the value the drug creates for society and warn that lowering drug prices will reduce investments in new drugs. This Element responds to these arguments by showing that pharmaceutical companies (a) should have their drug prices regulated, given scale economies in supplying drugs and price inelasticity of drug demand; (b) use their profits from unregulated drug prices to distribute cash dividends and stock buybacks to shareholders; (c) do not typically rely upon investment by shareholders to fund drug innovation; and (d) benefit from 'collective and cumulative learning' in foundational and translational research that is antecedent and external to their investments in clinical research.

Information

Type
Element
Information
Online ISBN: 9781009708012
Publisher: Cambridge University Press

Accessibility standard: Inaccessible, or known limited accessibility

The PDF of this Element is known to have missing or limited accessibility features. We may be reviewing its accessibility for future improvement, but final compliance is not yet assured and may be subject to legal exceptions. If you have any questions, please contact accessibility@cambridge-org.demo.remotlog.com.

Content Navigation

Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Index navigation
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.

Reading Order & Textual Equivalents

Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
Short alternative textual descriptions
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
Full alternative textual descriptions
You get more than just short alt text: you have comprehensive text equivalents, transcripts, captions, or audio descriptions for substantial non‐text content, which is especially helpful for complex visuals or multimedia.

Visual Accessibility

Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.

Structural and Technical Features

ARIA roles provided
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.

Save element to Kindle

To save this element to your Kindle, first ensure no-reply@cambridge-org.demo.remotlog.com is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Innovation versus Financialization in the US Pharmaceutical Industry
  • Öner Tulum, The Academic-Industry Research Network, William Lazonick, The Academic-Industry Research Network
  • Online ISBN: 9781009708012
Available formats No formats are currently available for this content.
×

Save element to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Innovation versus Financialization in the US Pharmaceutical Industry
  • Öner Tulum, The Academic-Industry Research Network, William Lazonick, The Academic-Industry Research Network
  • Online ISBN: 9781009708012
Available formats No formats are currently available for this content.
×

Save element to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Innovation versus Financialization in the US Pharmaceutical Industry
  • Öner Tulum, The Academic-Industry Research Network, William Lazonick, The Academic-Industry Research Network
  • Online ISBN: 9781009708012
Available formats No formats are currently available for this content.
×